Logo

NeuroPointDx: Barbara Handelin, Tony Shuber

Sep 03, 2020

NeuroPointDx appointed Barbara Handelin and Tony Shuber as new board members. Both have experience in the development and commercialization of new molecular diagnostic tests. Handelin was founding director of the DNA diagnostics lab at Integrated Genetics, now part of Laboratory Corporation of America, and Shuber was chief technology officer and cofounder of Exact Sciences and Predictive Biosciences.

NeuroPointDx said the appointments signal the expansion of its pipeline of diagnostic and precision medicine offerings in autism and other complex brain disorders, including anxiety and depression.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.